Scientific Updates to Improve Outcomes in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis

Target Audience

Dermatologists and dermatology advanced practice providers involved in the care and treatment of patients with moderate-to-severe atopic dermatitis

Program Overview

This interactive, virtual CME program will highlight recent advances in the treatment and management of moderate-to-severe atopic dermatitis, particularly in the adult patient population. The expert faculty, Drs. Jonathan Silverberg and Eric Simpson, will first review the immunopathology of atopic dermatitis as well as current guidelines for both adolescents and adults. Following, recent clinical trial data, including that of JAK-1 Inhibitors, will be analyzed and clinical implications debated in an interactive panel format. The expert faculty will conclude with a review of the vital role that the interprofessional team plays in educating and caring for patients with atopic dermatitis.

Agenda

I. Welcome and Introductions 

II. Immunopathology, JAK-1 Inhibitor-Based Therapeutic Targets, and Updated Guidelines for Adolescents and Adults with Moderate-to-Severe AD 

III. Clinical Trial Update for Therapeutic Options, Including JAK-1 Inhibitors, for Moderate-to-Severe AD

IV. Optimizing the Role of the Dermatology Care Professional to Treat Adolescents and Adults with AD

V. Interactive Expert Panel Discussion

Educational Objectives

1. Discuss the immunopathology, therapeutic targets including JAK-1 inhibitors, and recently updated guidelines for moderate-to-severe atopic dermatitis
2. Analyze recent clinical trial data of current and emerging therapeutic options to treat adolescents and adults with moderate-to-severe atopic dermatitis
3. Optimize the role of the dermatologic healthcare team in the management of adolescent and adult patients with moderate-to-severe atopic dermatitis

Faculty

Jonathan Silverberg, MD, PhD, MPH
Assistant Professor
Departments of Dermatology, Preventive Medicine and Medical Social Sciences
Feinberg School of Medicine at Northwestern University
Northwestern Medicine Multidisciplinary Eczema Center
Chicago, Illinois

Eric Simpson, MD, MCR
Professor of Dermatology
Department of Dermatology Oregon Health & Science University
Portland, Oregon

Joint Accreditation Standards for Commercial Support

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit™.

Participants should claim only the credit commensurate with the extent of their participation in the activity.

CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact [email protected] or 610-687-3300.

Financial Support

This activity has been supported by an independent educational grant from Pfizer Inc.

——–

Provided by AcademicCME

Registration